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Deceased organ donation has increased rapidly since
2002, coinciding with implementation of the Organ
Donation Breakthrough Collaborative. The increase in
donors has resulted in a corresponding increase in
the numbers of kidney, liver, lung and intestinal trans-
plants. While transplants for most organs have in-
creased, discard and nonrecovery rates have not im-
proved or have increased, resulting in a decrease in
organs recovered per donor (ORPD) and organs trans-
planted per donor (OTPD). Thus, the expansion of the
consent and recovery of incremental donors has fre-
quently outpaced utilization. Meaningful increases in
multicultural donation have been achieved, but do-
nations continue to be lower than actual rates of
transplantation and waiting list registrations for these
groups. To counteract the decline in living donation,
mechanisms such as paired donation and enhanced
incentives to organ donation are being developed. Cur-
rent efforts of the collaborative have focused on differ-
entiating ORPD and OTPD targets by donor type (stan-
dard and expanded criteria donors and donors after
cardiac death), utilization of the OPTN regional struc-
ture and enlisting centers to increase transplants to
match increasing organ availability.
Key words: Deceased donors, donation after car-
diac death (DCD), donation service area (DSA), ex-
panded criteria donor (ECD), living donor, multicultural
donation, Organ Donation Breakthrough Collabora-
tive, Organ Procurement and Transplantation Network
(OPTN), organ procurement organization (OPO), or-
gans recovered per donor (ORPD), Organ Transplanta-
tion Breakthrough Collaborative, organs transplanted
per donor (OTPD), Scientific Registry of Transplant
Recipients (SRTR)
Introduction
The major challenge in transplantation continues to be a
need for transplantable organs that far exceeds the avail-
able supply. This disparity and the ensuing waiting time to
receive a transplant result in considerable morbidity and
mortality among transplant candidates. A variety of initia-
tives in the past several years have been successful in sig-
nificantly accelerating what previously had been a relatively
slow increase in organ donation. Nevertheless, the contin-
ued development of methods to increase organ donation
and utilization is necessary to accommodate the increase
in the number of individuals who may benefit from trans-
plantation.
The increase in the supply of organs for transplantation is
multifactorial in origin. Much of the growth in organ dona-
tion has coincided with the establishment of the National
Organ Donation Breakthrough Collaborative through the
guidance of the Health Resources and Services Admin-
istration (HRSA) in September 2003. Focused efforts to
encourage multicultural donation have increased consent
and donation rates for most ethnic groups. The growth
of donor registries and recognition of the primacy of first-
person consent documentation have been instrumental in
increasing donation, as has the expansion of the donor
pool by increasing use of expanded criteria donors (ECD),
donors after cardiac death (DCD) and those standard cri-
teria donors (SCD) not previously considered for organ do-
nation. These influences are interrelated and have led to
unprecedented numbers of donor consents and organ re-
coveries.
As this article will describe, the effect of these increases
in donation on organ recovery rates and, in turn, on trans-
plantation rates is often incomplete. The degree of ineffi-
ciency varies by organ and may be reflected in increases
in nonrecovery of organs, discard rates or both. The co-
ordination of criteria for organ recovery by organ procure-
ment organizations (OPOs) with criteria for transplantabil-
ity by centers is a particular focus of current organ dona-
tion initiatives. Efforts are aimed at increasing organ uti-
lization by centers, more precisely defining transplantabil-
ity by OPOs, and more efficiently placing and transporting
marginal organs to centers willing to use them. To this end,
recent emphasis has focused on creating and evaluating




Efforts and Accomplishments of the
Collaborative in the Past Year
In 2003, HRSA, part of the Department of Health and
Human Services, joined with key national leaders and prac-
titioners from the nation’s transplantation and hospital com-
munities to launch the Organ Donation Breakthrough Col-
laborative. The goal of this initiative and its successors,
the Organ Transplantation Breakthrough Collaborative (ini-
tiated in 2005) and the Organ Donation and Transplantation
Breakthrough Collaborative (initiated in 2006), is to increase
the number of organs available for transplantation and the
number of organ transplants in the United States. This col-
laborative process has been described elsewhere but is
based upon techniques of improvement science described
by Berwick (1). These practices include establishment of
goals, agreement on best practices, rapid adoption of those
practices and a review of the results among the constituen-
cies of the improvement effort. In the transplant commu-
nity, that constituency has involved OPOs, donor hospitals
and transplant centers.
Organs available for transplant increased 24% after the ini-
tiation of the Organ Donation Breakthrough Collaborative,
with a concomitant decline in deaths on the waiting lists
nationally. In 2006, the total number of donors increased
to over 700 donors per month for several months in a row.
There was a significant increase in all types of donors, with
the largest numerical increase seen in SCD.
During the past year, the Organ Donation and Transplan-
tation Breakthrough Collaborative has been charged with
meeting the established goals of 3.75 organs transplanted
per donor (OTPD) and a 75% conversion rate for all po-
tential organ donors. The conversion rate is defined as
the number of deceased donors meeting eligibility criteria
(aged 0–70 years with neurological death) divided by the
number of eligible deaths (any ventilated death reported by
a hospital that is evaluated and meets organ donor eligibility
requirements). The Collaborative has also been tasked with
increasing DCD to 10% of all deceased donors without de-
creasing the number of donors after brain death (DBD).
In order to acknowledge different achievable results from
each donor type, in 2007 OTPD targets were reset based
on organ donor type. New sub-goals of 4.3 OTPD for SCD,
2.5 OTPD for ECD and 2.75 OTPD for DCD were estab-
lished. Information shared at collaborative learning ses-
sions involved donor management goals to (i) increase the
number of organs recovered and improve their outcomes,
(ii) define thresholds to increase DCD and (iii) develop rec-
ommendations for systems designed to maximize organ
acceptance. Unlike previous initiatives, the Organ Donation
and Transplantation Breakthrough Collaborative has been
actively integrated into the efforts of donation service area
(DSA) national improvement leaders, the Organ Donation

















Source: 2007 OPTN/SRTR Annual Report, Table 1.1.
Figure 1: Total number of deceased donors of all organs re-
covered for transplant, 1997–2006.
societies such as the American College of Healthcare Ex-
ecutives.
In 2007, the collaborative reached out to the OPTN regional
structure to assist in evaluation of performance gaps for
donor conversion rates and OTPD and to provide an ad-
ministrative structure to regionalize collaborative efforts. A
meeting was held in April 2007 in Atlanta to perform gap
analysis (comparison of the current state versus the de-
sired state of conversion rates) with representatives from
OPOs, donor hospitals, transplant centers and the OPTN.
By enlisting the established OPTN administrative struc-
ture, the collaborative is enabling the transplant centers
and OPOs to work together on a regional basis to im-
prove conversion rates in their regions. Using the 8024
deceased donors realized in 2006 (Figure 1), if every OPTN
region and DSA met target rates, there would be 5535
more transplants per year, a 23% increase. In Figures 2 and
3, the conversion and OTPD gaps are delineated by OPTN
regions, with a wide range of rates for both metrics. Similar























Source: 2007 Organ Transplantation Breakthrough Collaborative.
Figure 2: Collaborative conversion rate by region, 2006.



















Source: 2007 Organ Transplantation Breakthrough Collaborative.
Figure 3: Actual OTPD by region, 2006.
The current Transplant Growth and Management Collab-
orative was created in 2007 to focus attention on nation-
wide transplant center capacity. While there has been an
identifiable increase in the number of organs available, it
is unclear if transplant center capacity across the country
is adequate to use all transplantable organs. The aim of
this initiative is to increase the number of organs trans-
planted at each program by giving centers the tools to
examine their own practices. Goals have been set for in-
creasing the number of transplants performed by each cen-
ter by 50% over the next 5 years. Similar to other collab-
orative initiatives, transplant centers were identified that
were already meeting established goals. These centers
were identified by high volumes of transplants, high trans-
plant center growth rates, and low graft failure and patient
mortality rates. These centers represented myriad admin-
istrative structures, including traditional academic medical
centers, for-profit organizations and private-practice cen-
ters. Once identified, they were visited by members of
the HRSA team, collaborative faculty and an independent
consulting group to discern what practices allowed these
centers to perform at a high level. The policies, manage-
ment styles, organizational structure and financial aspects
of each center were evaluated. The inclusion of financial
practices and efficiency among ‘best practices’ is note-
worthy, amid concerns about the costs associated with
increasing use of ECD and DCD organs (2,3). These prac-
tices were then vetted through an expert panel in the
spring of 2007 to establish a set of ‘common drivers of
change’.
The most important common feature among high perform-
ing centers was a clear and established institutional com-
mitment and vision, such that transplant services were
part of the strategic plan of their health systems. Trans-
plant services were recognized by these institutions for
both financial contributions to the organization and non-
monetary benefits such as trainee education and research
opportunities. In most centers, there was a clear, collabora-
tive administrative structure between the chief executive
officers (CEOs), chief financial officers and the transplant
center director. High performing centers also focused on
recruitment and retention of a dedicated team of proactive
personnel, including clinical and administrative leaders, fi-
nancial and nurse coordinators, pharmacists and physician
extenders. There was a clear ‘chain of command’ in these
centers for both clinical and fiscal decisions; there was also
a collegial, nonhierarchical team approach to care such that
team members were valued for what they could contribute
to the overall mission and program. All centers shared a
proactive clinical management approach that was learning
based, through both experience and knowledge of perti-
nent medical literature. In most cases, each program had a
biweekly or weekly conference to review organs accepted
and rejected, with OPO follow-up for those organs trans-
planted elsewhere. By reviewing these types of program-
specific thresholds, organ-acceptance thresholds could be
raised or lowered based on the programmatic and literature
experience (Table 1).
As with many patient safety initiatives, hospital leadership
is being engaged from the outset to ensure that within
each institution, programs and teams have sufficient sup-
port. Invitations to transplant center CEOs and depart-
ment chairs to participate in this new effort have been
extended across the country by HRSA. Institutional teams
have been charged with analyzing the potential for growth
and outcomes in their individual transplant programs. Team
composition must include a transplant surgeon and/or
physician, a transplant coordinator, a transplant adminis-
trator, a quality improvement expert and a senior procure-
ment representative from the OPO. Teams from each
center and representatives from their OPOs convened a
national learning congress in October 2007 to begin the
dissemination of best practices and the transfer of knowl-
edge that can lead to an increase in transplant capacity
nationally.
Trends in Deceased Organ Donation
Deceased donors
The rate of growth in the yearly number of deceased
donors has markedly increased since 2002 (Figure 1),
which corresponds to the initiation of the Organ Dona-
tion Breakthrough Collaborative. Prior to 2002, deceased
donors had increased since 1997 at an average rate of 142
donors per year. Since 2002 that increase has jumped to a
yearly average of 459 donors per year. This continued be-
tween 2005 and 2006 with an increase of 431 donors to
8024.
While increases are observed in all three donor categories
(SCD, ECD and DCD), their distribution among the donor
population has changed since 2002. The decline in the per-
centage of SCD seen since 1997 accelerated in 2002, due
to larger increases in the numbers and percentage of ECD
and DCD (Figure 4). (In the Annual Report tables, DCD that
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Table 1: Best practices from high performing transplant programs from the Transplant Growth and Management Collaborative
Driver/strategy for change Key change concepts Examples of action items
1. Institutional vision and
commitment
Establish transplant as a high priority for health
systems
Establish transplantation as a priority service for the
hospital and set goals for transplant program
growth
Develop a business plan that will secure institutional
investment and support
Demonstrate the clinical, economic and
nonmonetary benefits of transplant
Organize transplant services into a service line Integrate all transplant services into a single service
line with designated budget and decision-making
authority
2. Dedicated team of
personnel
Organize around proactive surgeons and medical
doctors
Recruit and retain aggressive, experienced and
high-performing surgeons and medical doctors
with a passion for, commitment to and focus on
growing transplantation
Recruit, train and retain program staff who are
specialized, dedicated and committed
Have transplant program staff that work exclusively
on either transplant or one organ-specific
transplant program
Establish and live by a collegial, nonhierarchical
team approach to care
3. Build a financial case Track and understand your program costs and
revenues
Establish the transplant program as a separate cost
center
Negotiate payer contracts with awareness of
program finances and strengths
Model contracts and rates after program costs and
actual patient resource use
4. Patient and family
centered care
Offer a broad array of services Offer end-stage organ care with transplant services
as part of the continuum
Educate patients and families early and often Conduct regular, accessible education sessions for
potential transplant candidates and their families
about the benefits and risks of transplant and the





Create a high threshold for refusing organs Surgeons take all calls and there is a senior advisor
always available
Be on the cutting edge of research Participate in innovative clinical trials, new
immunotherapy regimes
meet the ECD kidney definition are classified as ECD.) The
most rapid numerical increase since 2002 has been in ECD,
with an average yearly increase of 186 donors per year
compared with an average of 177 SCD and 96 DCD. How-
ever, between 2005 and 2006 there was an increase of only
one ECD donor, from 2108 to 2109, while SCD increased
from 5033 to 5377, a 7% increase. The largest percentage
increase in donors in recent years has been in DCD. DCD
continues to increase in number, from 452 in 2005 to 538
in 2006 (19% increase).
The number of organs consented (potentially recoverable
organs from all donors who have donated at least one solid
organ) per year has increased significantly since 2002, with
a 34% overall increase (14152 organs) between 2002 and
2006 (Figure 5). A similar trend was seen in the number
of organs transplanted per year, which increased by 4051
(20%) between 2003 and 2006. However, the increase was
even more pronounced for the number of organs that were
not recovered, which increased by 8321 (44%) between
2002 and 2006. Discarded organs increased by 54% (1050
organs) between 2003 and 2006. These trends continued
between 2005 and 2006 with an increase of 307 discarded
organs, 1123 organs transplanted (21% incremental dis-
card rate) and 2896 organs not recovered.
In 2006, 55360 organs were consented (potentially re-


















Source: 2007 OPTN/SRTR Annual Report, Table 2.12; * includes DCD that 
meet ECD kidney criteria.
Figure 4: Deceased donor population, by donor type and year
(percentage).
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Source: 2007 OPTN/SRTR Annual Report, 3.1, 3.3, 3.4, 3.6, 3.7, 3.9, 3.10, 
3.12, 3.13, 3.15, 3.16, 3.18.
Figure 5: Number and disposition of all consented organs∗
from deceased donors, 1997–2006. (∗Potentially recoverable or-
gans from all donors who have donated at least one solid organ.)
recovered, 5% discarded and 1.6% used for research or
other purposes. The percentage of consented organs that
were transplanted has declined slightly from 49% in 2002,
while the percentage not recovered increased slightly to
49% over the same time interval. The percentage of re-
covered organs discarded has increased from 8% in 2003
to 11% in 2006. These data indicate that while consents,
recoveries and transplants are all increasing, rates of nonre-
covery and discard are also increasing. This is perhaps not
surprising, as the incremental increase in consents and re-
coveries are likely to be primarily from individuals (and of
organs) not previously considered to be suitable for dona-
tion (or transplant). It is also important to note that while it is
routine to obtain consent for all organs from every potential
donor, not every organ from a suitable donor is suitable for
transplant.
Even though the numbers of consents, recoveries and
transplanted organs have increased, especially since 2002,
other important markers of organ donation have not dra-
matically changed much over the last 10 years (Figure 6).
The number of organs recovered per donor (ORPD) and
OTPD have declined slightly since 2002. The ORPD
dropped from 3.62 in 2002 to 3.52 in 2006, and the OTPD
dropped from 3.23 to 3.05. These trends also probably re-
flect increases in donors that are not multiorgan donors,
including significant increases in DCD. Thus, the increase
seen in the number of organs transplanted has resulted
from increases in consents and recoveries rather than in
improvements in their rate of recovery or discard. These
trends coincide with the implementation of the Organ Do-
nation Breakthrough Collaborative, and trends in donation
and utilization of individual organs tend to follow these over-
all patterns.
This trend in decrease of ORPD and OTPD is not neces-
sarily surprising, as some of the increase in organ donors
is likely to be from older or less healthy donors. In addition




















Source: 2007 OPTN/SRTR Annual Report, Table 2.12.
Figure 6: ORPD, OTPD All Organs, 1997–2006.
lence rates for several chronic diseases are rising. The de-
mographic shifts, individual behaviors and environmental
effects combine to create significant negative effects on
health outcomes. This burden of chronic disease has a no-
table impact on the supply as well as the demand for or-
gans. One of the factors limiting the supply of available
organs is the number of organs rejected by transplant cen-
ters because of poor organ function or an unsatisfactory
medical history of the donor related to a chronic disease
or other medical condition. While to date, no published
descriptive report has looked at the possible impact of
chronic disease on organ transplantation and donation in
the United States, the disparity between the increase in
consented organ donors and the more modest increase in
transplants can be at least partially attributed to an over-
all decrease in organ quality based on chronic disease and
the increasing numbers and types of organ donors being
considered.
The age distribution of deceased donors is increasing,
albeit somewhat slowly. The percentage of donors age
17 years or less was 12% in 2006 compared with 15% in
2002, while the percentage of age group 18–34 years de-
creased from 28% to 26% over the same time interval. In
contrast, the percentage of donors age group 50–64 years
increased from 23% in 2002 to 26% in 2006 and those of
age 65 years or older increased from 9% to 10%. In the
past year, this trend stabilized. There was an increase of
0.7% in donors ages 35 to 49 years, which was matched
by a similar decrease in donors ages 65 years or older.
With the changing donor demographic, the cause of death
among donors has also shifted. The percentage of donors
dying from anoxia has increased over the last 6 years,
growing from 10% in 2000 to 17% in 2006. This
has been accompanied by a similar decline in the
percentage of deaths due to head trauma, dropping from
42% in 2002 to 38% in 2006. The distribution of causes
of death in the other categories (cerebrovascular/stroke,
central nervous system tumor and other) has remained rel-
atively stable since 1997.
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Race, ethnicity and multicultural donation
The number of African American and Hispanic/Latino or-
gan donors each year in the United States has dou-
bled over the past 10 years, while Asian donors have
increased by 62%. This growth reflects a combined effect
of increases in US multicultural populations and increases
in donation rates among two of these three ethnic groups.
Specifically, while African Americans constituted 12.2% of
the US population in 2000, they made up only 11.9% of
donors in that year. By 2006, the African American pop-
ulation had changed only slightly to 12.3%, but African
American donors made up 15.6% of total US organ donors.
Similarly, Hispanic/Latinos were 12.6% of the popula-
tion in 2000 and 10.4% of organ donors; by 2006, His-
panic/Latinos were 14.8% of the US population and 13.7%
of the donor population. Thus, these two groups have in-
creased in both raw numbers and proportion of donors.
The US Asian population has also grown as a percent-
age of population, increasing from 3.8% in 2000 to 4.4%
in 2006, but Asian donors as a percentage of total US
donors remained flat at 2.4%, despite a 39% increase in
the actual number of Asian donors over the same time
period (4).
The sources of this growth, identified by OPO staff and the
Organ Donation Breakthrough Collaborative, have come
primarily in areas with large concentrations of specific eth-
nic groups, such as the West and Southwest for His-
panic/Latino donors and the Midwest and eastern urban
areas for African American donors. Those OPOs demon-
strating the highest rates of increase have routinely fo-
cused specific staff and training investments to ensure that
approach and consent staff members have language skills
and cultural awareness experience and training to address
the specific needs of these distinct audiences. Areas with
statistically smaller populations of multicultural staff have
a harder time allocating resources to serve these groups,
as well as difficulty recruiting staff with specific capabili-
ties to fulfill these needs. Thus, need for and experience
with serving the specific needs of multicultural commu-
nities is strongly associated with improved consent rates
among those communities. Another area of OPO and com-
munity investment often associated with higher multicul-
tural donation rates is public education, such as paid media
advertising and school programs focused on these groups.
The data to support these claims remains sparse, but Span-
ish language donation advertising may show an association
with increased consent rates and with significant increases
in donor registration during and following focused media
buys.
These increases in multicultural donation are substantial
and meaningful, though they remain lower than the ac-
tual rates of transplantation and waiting list registrations
for these groups. In 2006, while African Americans rep-
resented 15.6% of donors, the group made up 19.4%
of transplant recipients and 27.9% of waiting list pa-
tients. Hispanic/Latinos were 13.7% of donors, 12.5%
of recipients and 16.0% of the waiting list population.
Asians were 2.4% of donors, 4.4% of recipients and
6.3% of the waiting list patients. The gap between do-
nation rates and transplant rates remains, in part, due to
an even greater representation of some groups among
waiting list registrants relative to their population pro-
portion. This discrepancy likely reflects a greater burden
of chronic disease, which also may limit organ donation
potential.
The measure of donation rate relative to potential—first re-
ported in the 2004 edition of this analysis (5)—highlights
the opportunity that remains. That measurement, from the
Association of Organ Procurement Organizations (AOPO)
Death Record Review study, identified that African Amer-
icans constituted 20.6% of the potential donors and 12%
of donors that year, while whites were 82.8% of donors
but only 70.9% of potential donors (6). Similarly, His-
panic/Latino, Asian and ‘Other’ potential donors for that
period made up 8.5% of the US total donor potential, but
only 5.2% of actual donors for the period. Thus, while in-
creases in multicultural donation have led to donation rates
that often exceed population proportions, disproportionate
representation of these groups among potential donors
suggests opportunity for further improvement in donation
rates among all three ethnic groups.
This gap is currently measured only by individual OPOs
tracking consent and conversion rates by race, and it has
not been consistently captured in the OPTN reporting pro-
cedure. Recently adopted changes in OPTN policy should
result in this information being collected for the 2008 calen-
dar year. Having this data may be useful for OPOs, helping
them focus donor development efforts, public education
campaigns and approach and consent methods of OPO
staff. The results of these improvements are underscored
by data showing the 16 OPOs with conversion rates of
75% and higher in 2006–2007 (based on data from the Or-
gan Donation and Transplantation Breakthrough Collabora-
tive, using data from hospitals with eight or more eligible
deaths). Of this group, the proportion of donors classified
as white was as high as 96%, with a mean of 78.5% and
a median of 84.8% (7).
These data lead to the conclusion that while substantial
progress has been made in the effort to increase mul-
ticultural donation, consent and conversion rates among
African American, Hispanic/Latino and Asian populations,
donation rates for each of these groups still lag be-
hind those of the white population. These data identify
opportunity for focused efforts to increase donor des-
ignation for these groups on donor registries and for
OPOs to tailor and equip approach and consent processes
and staff to address the unique information needs and
sensitivities of multicultural potential donors and their
families.





















Source: Donate Life America Donor Designation Collaborative Dashboard Data 
Snapshot, 2007.
Figure 7: Percentage of deceased or-
gan donors identified by a registry, 1Q
2007.
State donor registries: a critical role
The growth in state-authorized organ and tissue donor reg-
istries since 1993 has given donors, families and transplant-
related organizations an invaluable tool to help increase
consent rates and recovery of organs, eyes and tissues
for transplant. Unlike donor cards, computerized state reg-
istries do not rely on a paper document that is rarely avail-
able when a family is approached for consent. In most
states, a donor designation through a state registry consti-
tutes first-person consent that is legally binding and thus
cannot be rescinded by family members. In addition, be-
cause consent is preauthorized in such cases, the organ
placement and recovery process begins sooner, saving pre-
cious time that can result in more organs remaining viable
for transplant.
As of August 2007, 44 states have registries to sign up
designated donors (8). The share of designated donors var-
ied greatly by state, but 16 states have signed up more
than half of their licensed drivers as such. The range of
licensed drivers registered as donors among established
registries runs from California’s 2-year old program at 5%
to Utah’s long-established registry at 71%. Among the 25
states reporting data for the first quarter of 2007, 25% of
recovered organ donors were authorized (in first-person
consent states) or identified (in intent-only states, i.e.,
participation-designated intent that carries no legal status)
through donor registries (8). This ranges from a high of 59%
in Virginia to a low of 1% in California (Figure 7). In addi-
tion, of 24 states reporting during the same period, 25%
of recovered tissue donors were authorized or identified
through registries (8).
The most effective registries are those affiliated with their
respective state departments of motor vehicles and offer-
ing a check-box sign-up process. A national initiative, Do-
nate Life America’s Donor Designation Collaborative, is fo-
cused on designing registries to be as effective as possible
and sharing best practices to meet the national goal of 100
million actionable donor designations.
These data indicate that donor registries are beginning
to play a critical role in donation and transplantation and
should be expected to be of growing significance as the
Donor Designation Collaborative continues to share reg-
istry best practices in the coming years.
DonorNet 2007
One of the most notable recent developments in organ do-
nation has been the introduction of DonorNet 2007, which
was developed by the United Network for Organ Sharing.
By permitting the simultaneous electronic notification of or-
gan offers, this system represents a fundamental change
in the organ placement process, one designed to improve
efficiency and therefore utilization.
Because DonorNet 2007 makes it possible to make mul-
tiple offers simultaneously, the extraordinary increase in
the volume of offers has resulted in unwanted offers for
many centers. In response to feedback from the transplant
community, the OPTN has implemented mechanisms that
increase the flexibility of the system by allowing transplant
centers to be more specific and selective in the offers
they will receive for their candidates. These modifications
should enable users to tailor the system to their needs;
the current emphasis is on the addition of capabilities to
allow centers to restrict the offers made for their patients
to those they are most likely to accept. A specific exam-
ple is the change that allows centers to specify distance
for kidney/pancreas and pancreas offers for their respec-
tive centers; this modification resulted in a 24% decrease
in pancreas offers. Another recent modification permits
transplant center organ-specific acceptance criteria to be
separated between local and import offers, which is likely
to significantly decrease the number of unwanted organ of-
fers. Future implementations may allow centers to stratify
organ acceptance criteria by candidate.
The OPTN has been working in conjunction with the
leadership of AOPO through its Procurement Council to
disseminate best practices and lessons learned in
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using DonorNet 2007 so that organs are placed efficiently.
Additional upgrades are a result of specific feedback that
the transplant community has provided to OPTN staff and
the Electronic Organ Placement Working Group. These
measures should help reduce the required resources de-
voted to organ offer evaluation and acceptance that may
have transiently increased under the new system. Equally
important, the elimination of unwanted offers should en-
hance the efficiency of organ placement by restricting of-
fers to those centers most likely to accept them. Such ef-
ficiency should reduce times to offer, increase acceptance
rates, reduce discard rates, decrease cold ischemia times
and improve outcomes.
Organ-specific deceased donation and utilization
While the overall patterns of increase in consent and uti-
lization for specific organs parallel those for organ donors
in general, organ-specific considerations may affect how
these patterns are reflected in specific utilization metrics.
Lack of use can be reflected in either nonrecovery or dis-
card (research use also represents a small percentage of
those organs not transplanted). Whether an organ is not re-
covered or is discarded depends on donor-specific factors,
but may also be determined by how organs are evaluated.
For organs that are evaluated exclusively either preopera-
tively or intraoperatively by the transplanting center, such
as heart, liver, lung and intestine, lack of use is much more
likely to take the form of nonrecovery, and corresponding
discard rates are low (<5%). In addition, the discard rate of
<1% for hearts is likely to reflect the limited cold ischemia
time and corresponding logistic constraints. For some or-
gans, such as kidney and, to a lesser extent, pancreas, an
important part of the evaluation process occurs postrecov-
ery, and the organs are often recovered by teams not af-
filiated with the transplant center. These organs are much
more likely to be recovered and subsequently discarded;
thus their discard rates are higher (>10%).
To place donation and utilization trends in context with the
overall imbalance of organ supply and demand, waiting list
data are provided below for each organ type.
Deceased kidney donation and utilization. The number
of candidates on the kidney transplant waiting list stood
at 66961 at the end of the year 2006, an increase of 88%
since 1997. In 2006, there were 15630 potentially recov-
erable (consented) kidneys. Of these, 1348 (9%) were not
recovered, 2127 (14%) were recovered but discarded and
11906 (76%) were transplanted, all increases over 2005.
The percentage of kidneys that were not recovered has
gradually increased from 6% in 1997 to 9% in 2006. This
is much lower than the overall average nonrecovery rate of
49%. The percentage of recovered kidneys that were dis-
carded has gradually increased from 10% in 1997 to 16%
in 2006. Despite the increase in discard rate, the large in-
crease in recovered kidneys since 2002 has resulted in
a corresponding increase in the number of kidneys trans-
planted, from 9694 in 2002 to 11 906 in 2006, a 23% in-
crease. The percentage of consented kidneys that were
transplanted in 2006 (76%) was high relative to the overall
average of 44% for all organs.
Since 2002, of 3086 additional kidneys recovered, 1218 of
these have been SCD kidneys, 1137 ECD and 731 DCD.
The combined ECD and DCD contributions represent al-
most 61% of the increase during that time. However, of the
969 additional kidneys recovered between 2005 and 2006,
651 (67%) were SCD, 133 (14%) were ECD and 185 (19%)
were DCD. Together ECD and DCD kidneys now represent
almost 31% of all kidneys recovered. While the percent-
age of recovered SCD and ECD kidneys that were trans-
planted decreased in 2006 from the previous year (91.7%
from 91.9% and 57.9% from 59.4%, respectively), the per-
centage of recovered DCD kidneys transplanted increased
from 82% to 86%. These trends indicate that the contin-
ued expansion of the DCD kidney donor pool includes a
greater percentage of kidneys likely to be transplanted than
for SCD and ECD, where increases in recoveries have out-
paced increases in transplants.
Organ preservation solutions and pumping of kidneys.
Viaspan, also known as University of Wisconsin solu-
tion or Belzer’s solution, has been the primary flush so-
lution for abdominal organs over the past decade in the
United States. Custodiol, also known as HTK (histidine-
tryptophan-ketoglutarate) solution, had been used exten-
sively in Europe, and was recently approved by the FDA
for use as an organ preservation solution in this country.
Trends in kidney flush solution use, recorded by OPO as
the final flush solution, indicate an increase in the use
of Custodiol and a decrease in the use of Viaspan dur-
ing the last 3 years (Figure 8) (SRTR analysis, May 2007),
with Viaspan accounting for 63% of flushed kidneys, Cus-
todiol 28% and ‘others’ or ‘no flush’ 9% (SRTR analy-
sis, July 2007). An SRTR analysis of final flush solution
of kidneys and delayed graft function (DGF) found no differ-
ence in DGF rates between Viaspan and Custodiol (OPTN




















Source: SRTR analysis, May 2007.
Figure 8: Flush solutions for recovered kidneys, 2004–2006.























Source: SRTR analysis, May 2007; * includes kidneys from DCD that meet 
ECD criteria.
Figure 9: Kidney pumping trends.
As experience grows with the use of Custodiol, more in-
formation on graft survival should be available.
While a few centers have consistently used pumping for
nearly all recovered kidneys, the majority of kidneys re-
covered over the last decade were not pumped. With the
recovery of a greater number of ECD and DCD kidneys,
there has been renewed interest in the use of pumping,
not only to improve vasospasm and reduce DGF, but also
to assess vascular resistance as a method to identify kid-
neys that may not be suitable for transplant. The greatest
increase in pumping over the last decade has been for ECD
and DCD kidneys, with upward of 60% of recovered DCD
kidneys now pumped (Figure 9) (SRTR analysis, May 2007).
An SRTR analysis of pumping data from 2004 to 2006 found
that the overall impact of pumping on DGF appears to be
significant. If the pumping is initiated at the time of recov-
ery by the OPO, the rate of DGF for SCD kidneys is 15%
compared with 24% for those not pumped (OAC Commit-
tee Report of October 31, 2006). Interestingly, there was
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Source: SRTR analysis, 2005.
Figure 10: Relationship between DCD and non-DCD recov-
ered in 2004 (N = 59 DSAs).
that were pumped, with a DGF rate in these kidneys of
around 40%. There were also no trends in the risk of graft
failure for either increasing cold ischemia time or pump-
ing category for any type of kidney. Therefore, the ability
of pumping to decrease DGF for DCD or to improve graft
failure outcomes for DCD or ECD kidneys was not demon-
strated. Further discussions regarding the role of pumping,
and the possibility of a pumping mandate, continue.
Deceased liver donation and utilization. At the end of
2006, 16 861 candidates were on the liver transplant wait-
ing list, an 82% increase from 1997. In 2006, of 7888 con-
sented livers from organ donors, 6360 (81%) were trans-
planted, 431 (5%) were discarded and 804 (10%) were not
recovered. These are all increases from 2005. The nonre-
covery rate has declined slightly from 12% in 1997 to 10%
in 2006.
The percentage of recovered livers that are discarded has
remained relatively low over the 10-year interval, and was
6% in 2006. The increase in recovery since 2002, coupled
with the low discard rate, has resulted in a 28% increase
in transplanted livers between 2002 and 2006. The 81%
transplant rate among consented livers in 2006 was much
higher than the overall average of 44% for all organs. The
number of recovered DCD livers increased by about 5%,
from 389 in 2005 to 407 in 2006, and now represents 6%
of all recovered livers and 63% of all DCD donors. Over-
all, 89.9% of recovered livers were transplanted in 2006,
a decrease of 0.4% from 2005. While this percentage de-
creased from 91.6% to 91.1% for DBD, it increased from
69.7% to 71.0% for DCD donors.
Deceased pancreas donation and utilization. At year-
end 2006, there were 600 candidates on the waiting list for
a pancreas transplant alone, 994 candidates on the wait-
ing list for a pancreas after kidney transplant and 2360
candidates on the waiting list for a simultaneous kidney-
pancreas transplant. These figures represent increases of
167%, 572% and 58%, respectively, from 1997. Although
the number of potentially recoverable pancreata increased
by 1839 (39%) between 2002 and 2006, most of these
organs have not been recovered: the number of pancre-
ata recovered increased by only 154 between 2002 and
2006. The nonrecovery rate among pancreata is high and
has been increasing since 2002, from 60% to 69% in 2006.
The discard rate among recovered pancreata has also in-
creased gradually from 11% in 1997 to 18% in 2006. These
trends have resulted in the number of transplanted pan-
creata remaining relatively unchanged since 2002, after
a 38% increase between 1997 and 2002. In 2006, there
were 6524 pancreata consented, with 366 (6%) discarded,
4498 (69%) not recovered and 1404 (22%) transplanted. In
2006, 59 pancreata were used for islet transplantation, a
decrease from a high of 90 in 2002. The 22% transplant
rate is lower than the average of 44% for all organs. Recov-
ered DCD pancreata increased dramatically over the past
10 years from 4 to 73. The 73 DCD pancreata recovered in
2006 represent 4% of the total. Of these recovered DCD
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pancreata, 35 were transplanted (48%), compared with 32
in 2005.
The low recovery and transplant rates of deceased donor
pancreata are a focus of OPTN allocation policy efforts (9).
Pancreas recovery and transplantation are also character-
ized by extensive regional variation in these markers of
utilization, and efforts to facilitate the rapid placement of
pancreata to high volume regions and centers are being
investigated. The effectiveness of the electronic notifica-
tion system implemented in DonorNet 2007 regarding the
placement of pancreata will undoubtedly be assessed in
the next few years. The low utilization of pancreata from
donors older than 50 years and with a body mass index
greater than 30 provided the basis for a modification of the
OPTN pancreas allocation algorithm in 2006 to prioritize
these donors for allocation for islet transplantation after
local whole pancreas transplant.
Deceased heart donation and utilization. At the close of
2006, 2814 candidates were on the heart transplant wait-
ing list, down 26% since 1997. The number of potentially
recoverable (consented) hearts increased by 1583 (36%)
between 2002 and 2006. In 2006, of 6019 hearts from
organ donors, 2220 (37%) were transplanted, 12 (0.2%)
were discarded and 3744 (62%) were not recovered. Since
2004, the number of transplanted hearts has increased only
slightly from 2055 to 2220 in 2006. The increase in con-
sents has not translated into an increase in transplants due
to a nonrecovery rate that has been growing since 2001.
The discard rate for recovered hearts has remained very
low since 1997, less than 0.7%.
Deceased intestine donation and utilization. At the end
of 2006, 238 candidates were on the intestine transplant
waiting list, an increase of 171% since 1997. In 2006,
of 6145 intestines from organ donors, 172 of these (3%)
were transplanted, eight (0.1%) were discarded and 5961
(97%) were not recovered. While the number of available
intestines has increased dramatically since 2002 (by 2074
organs, a 51% increase), most of these organs were not
recovered; intestines have the lowest recovery rate of any
organ (between 2% and 3.5% over the last 10 years). This
is a result of the small numbers of candidates on the wait-
ing list and the limited number of programs performing
intestinal transplants. However, because of the historically
low discard rate among recovered intestines (4% in 2006),
the increase in recoveries has resulted in an additional 66
organs transplanted in 2006 (62% increase) compared with
2002.
Deceased lung donation and utilization. At the close of
2006, there were 2857 candidates on the lung transplant
waiting list, an increase of 11% from 1997, but a decrease
from 3124 candidates in 2005, when the Lung Allocation
Score was introduced. In 2006, of 13154 lungs from or-
gan donors, 2360 of these (18%) were transplanted, 46
(0.35%) discarded and 10694 (81%) not recovered. With a
marked increase in the number of lungs consented since
2002 (3212 lungs, a 32% increase) and a very low dis-
card rate among recovered organs (under 5% since 1997),
the percentage of lungs transplanted has increased since
2002, despite a historically low recovery rate between 15%
and 20%. The 2360 lungs transplanted in 2006 reflect an
increase of 739 organs (46%) over 2002. The contribution
of DCD lungs remains low but continues to grow slowly,
up from 16 lungs recovered in 2005 to 22 lungs recov-
ered in 2006. This represents less than 1% of the total
recovered. All 22 lungs recovered from DCD in 2006 were
transplanted.
DCD trends and impact on donation after brain death
DCD have increased 15% (from 561 to 645) from 2005 to
2006. Concerns have been raised that this increase has
occurred at the expense of non-DCD, since theoretically
some DCD could progress to DBD if DCD did not occur.
Since ORPD and OTPD are lower for DCD, this has po-
tential implications for organ utilization. With implemen-
tation of the first accreditation standard for DCD by the
Joint Commission, clarification of this issue is important.
The relationship between DSA donation rate (defined as
the number of donors meeting eligibility criteria [non-DCD,
age ≤70 years divided by the number of eligible deaths])
and DCD as a percentage of total donors is neutral, indicat-
ing that non-DCD donation is not necessarily a driving force
for increased DCD (SRTR analysis, April 2005). Indeed, the
16 DSAs accounting for 80% of DCD show an increase
in all donor types, namely SCD, ECD and DCD. In 2004,
donation counts for non-DCD versus DCD in the 59 DSAs
were positively correlated (R = 0.41, p = 0.001) (Figure 10)
(SRTR analysis, April 2005). This indicates that DSAs that in-
creased DCDs had a corresponding increase in non-DCDs.
The same relationship was demonstrated when the anal-
ysis was repeated with SCD only (excluding ECD) versus
DCD (R = 0.39, p = 0.004, not shown). Finally, there was
no relationship demonstrated between the DSA change in
DCD between 2003 and 2004 and the change in DBD over
the same interval, indicating that DSAs that increased DCD
appeared not to do so by preempting DBD (SRTR analysis,
April 2005).
Trends in Living Donation
The number of living donors declined for the second con-
secutive year, after increasing by 73% since 1997. There
were 6732 living donors in 2006, down 166 (2%) from
2005. This trend, combined with the recent increase in
deceased donors, has resulted in the number of deceased
donors exceeding the number of living donors for the third
straight year. Since 1997 the vast majority of organs from
living donors have been kidneys (96% in 2006), followed
distantly by livers (4% in 2006), and last (less than 0.1%)
by other organs. The small decrease in living donors in
the past 2 years may represent a saturation point in the
supply of living donors, or it may be related to the in-
crease in transplants from deceased donors. An important
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potential influence is the increased emphasis at multiple
levels (transplant community, regulatory agencies, media)
on preserving the health of the living donor.
Living kidney donation
After growing from 3933 donors in 1997 to 6647 donors in
2004, living kidney donation leveled off and has since de-
clined slightly to 6436 donors in 2006. The percentage of
donors in the age group 50–64 years has increased grad-
ually over the past decade to 22% in 2006, up 1% from
2005. Between 2005 and 2006 the percentage of donors
in the 18- to 34-year age group remained unchanged at
32%, while donors in the age group 35–49 years declined
to 46%. The youngest and oldest age categories continue
to be represented by only a small fraction of donors; there
were no donors in the 11- to 17-year age group in 2006,
and only 1% of all donors were older than 65 years.
The number of full sibling and parent living donors has
not changed much over the last 10 years, but the per-
centage of all donors in those categories has declined as
other donor relationships have become more common. Al-
though there are still more living kidney donors in the ‘full
sibling’ category than any other, they declined from 40%
of all donors in 1997 to 25% in 2006. The percentage of
parent living donors has dropped from 19% in 1997 to 10%
in 2006. The percentage of ‘spouse unrelated’ and ‘other
relative’ donors has remained relatively constant over the
past 10 years. The most dramatic increase has come from
‘other unrelated’ donors, which has increased from 274
in 1997 to 1538 in 2006, and now represents 24% of all
donors, the second largest category. These types of donors
may include friends, co-workers, and also nondirected
or ‘Samaritan’ donors. Offspring living donors represent
the third largest category, unchanged at 18% for the last
2 years.
The race and sex distribution of living kidney donors has not
changed significantly over the last 10 years. The majority of
donors have been white, representing about 69% to 71%
of the total. African American and Hispanic/Latino donors
have each made up similar proportions, around 13–15%
and 11–13%, respectively. Asian donation has ranged be-
tween 3% and 4%, while donors in the ‘other/multi-racial’
and ‘unknown’ categories have never represented more
than 1% of all donors. Female donors have been more
common over the decade, ranging from 57% to 59%.
Living liver donation
The number of living liver donors decreased slightly to 287
in 2006, from 323 in 2004 and from a high of 520 donors in
2001. The composition of the living liver donor population
has changed over the past decade. In 1997, 84% of living
liver donors were parents. By 2006, due to the increase in
the performance of adult living donor liver transplantation,
this dropped to 17%, the same percentage as full sibling
donors and ‘other unrelated’ donors. Offspring now rep-
resent the leading category of living liver donors, 27% in
2006. ‘Other relative’ donors make up an additional 12%
of all living liver donors in 2006, and spousal donors make
up 5%. In 1997, 71% of living liver donors were in the age
group of 18–34 years, almost 26% were in the 35- to 49-
year age group, and less than 4% were in the age group
of 50–64 years. By 2006 the percentage of donors in the
18- to 34-year group dropped to 49%, the percentage who
were 35–49 years increased to 36% and the percentage
in the 50- to –64-year group gradually increased to 15%.
These age trends indicate a steady increase in the average
age of living liver donors over the last 10 years. The demo-
graphics of race and sex have remained relatively stable
in the living liver donor population in the same period. The
percentage of white donors in 2006 was 81%, increased
only slightly from 77% in 1997. Just more than half (51%)
of living liver donors were females in 2006. In 2006, the
most common diagnoses for living donor liver recipients
were noncholestatic cirrhosis (40%), cholestatic liver dis-
ease/cirrhosis (23%) and biliary atresia (13%). This repre-
sents a marked difference from 1997 when biliary atre-
sia accounted for 57% of living donor liver recipient diag-
noses, compared with noncholestatic cirrhosis at 9% and
cholestatic liver disease/cirrhosis at 5%. The diagnosis of
‘malignant neoplasms’ among living donor liver recipients
started at a low of 2% in 1998, spiked to its highest point
of 9.1% in 1999 and then fluctuated over the years and
was at 8.7% in 2006.
Living pancreas donation
There was only one living donation of a pancreas in 2006.
Living lung donation
For the second year in a row, the number of living lung
donors has been very small. There were only five living
lung donors in 2006 and two in 2005, after dropping from
25 to 29 living lung donors per year between 2002 and
2004.
Paired kidney exchange
Willing living kidney donors found to be incompatible by
blood type or cross-match with their planned recipient
could potentially donate to another unrelated compatible
recipient who also has an incompatible donor, thereby set-
ting up a paired kidney exchange. Over the last few years,
there has appeared to be a growing interest in establishing
paired exchanges within transplant programs, within re-
gions and possibly on a national level. With increasing num-
bers of donors and recipients entered into such a program,
the chances of finding compatible pairs or even multiple
exchange possibilities (three-way or four-way exchanges)
increases (10). Unfortunately, the concept of this exchange
of kidneys was felt to possibly assign a value to an or-
gan, which is not allowed under the National Organ Trans-
plant Act (NOTA) passed in 1984. The Department of Jus-
tice ruling in March 2007 that kidney exchange programs
do not violate NOTA has paved the way for the further
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development of paired exchange programs. In addition, the
passage of the Charlie W. Norwood Living Organ Donation
Act by unanimous vote both in the House of Representa-
tives and in the Senate further removes legal obstacles to
paired donation, if enacted.
Paired exchange has not yet enjoyed widespread applica-
tion, with only 165 recipients undergoing paired exchange
transplant in the United States through 2006 (11). Several
consortia have been established, and other single center
programs have been established as well, using variations
of computer matching programs to identify pairs within the
center’s list. The drive to establish a national program re-
mains in the discussion and planning phase.
Before a nationwide program could be established, sev-
eral issues with exchanges between patients at different
centers need to be settled. These include the level of work-
up needed before a ‘pair’ is entered into the database for
matching; the logistics (and willingness) of donors and re-
cipients to travel, and of centers to ship kidneys (12); the
issue of dealing with levels of comfort on the part of var-
ious programs with proceeding with a given transplant;
and lastly how to handle the added expense and man-
power needed to allow such a complex program to run
efficiently. The role of paired donation over list-paired do-
nation schemes is also a controversial point that has an
effect not only on the success of paired exchanges, but
also on waiting times for deceased donor recipients, espe-
cially in blood group O. The exact impact of these exchange
programs on overall transplant rates remains to be seen.
Reimbursement of living organ donors
The receipt of valuable consideration in exchange for or-
gans is specifically prohibited by NOTA. However, ethically
and legally acceptable compensation mechanisms for ex-
penses or other financial losses incurred by donors and
their families as part of the donation process are being
considered.
In 2006, HRSA awarded a grant to provide reimbursement
of travel expenses and subsistence costs for living organ
donors, removing an important financial disincentive to liv-
ing organ donation. Awarded to the American Society of
Transplant Surgeons (ASTS) and the University of Michi-
gan, the grant will provide resources for the project team
and HRSA to develop an efficient national system to iden-
tify potential living organ donors facing financial hardship in
meeting travel and subsistence expenses associated with
the process of evaluation and undergoing live organ dona-
tion procedures.
Under provisions of the grant, a National Living Donor As-
sistance Center will be established, and the vast majority
of the $8 million grant will be used for direct reimburse-
ments to potential and actual living donors. The impact of
the reimbursement program on facilitating live organ do-
nations that would not otherwise have been possible will
be a specific research question. It is estimated that the
grant will make live organ donation possible for an addi-
tional 800–1000 individuals annually.
Summary
Rapid increases in deceased organ donation have been
achieved since the implementation of the Organ Donation
Breakthrough Collaborative in 2003, and have largely been
attributed to this effort. While on a percentage basis the
greatest recent increase has been in DCD, the greatest
numerical increase has actually been from SCD. Meaning-
ful increases in multicultural donation have been achieved.
The continued development and effectiveness of donor
registries have also contributed to the increase in organ
donation, with about 25% of donors having participated in
a registry (8).
This increase in organ donation has resulted in a corre-
sponding increase in the numbers of kidney, liver, lung and
intestine but not heart or pancreas transplants. However,
even for organs where transplants have increased, discard
and nonrecovery rates generally have not improved, which
has resulted in a decrease in the ORPD and OTPD. Thus,
the incremental increases in consent and recovery have
exceeded those in utilization, and waiting lists for most or-
gans continue to increase. Efforts at increasing utilization,
such as perfusion of kidneys and the electronic notifica-
tion system implemented in DonorNet 2007, continue to
be developed. Other mechanisms designed specifically to
reverse the decline in living donation, including living paired
donation of kidneys and enhanced incentives to organ do-
nation, are also being pursued.
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